AngioDynamics, Inc.
US ˙ NasdaqGS ˙ US03475V1017

Introduction

This page provides a comprehensive analysis of the known insider trading history of Charles R Greiner. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Charles R Greiner has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:ANGO / AngioDynamics, Inc. VP - Global Franchise 20,910
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Charles R Greiner. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases ANGO / AngioDynamics, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in ANGO / AngioDynamics, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ANGO / AngioDynamics, Inc. Insider Trades
Insider Sales ANGO / AngioDynamics, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in ANGO / AngioDynamics, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2016-05-06 ANGO Greiner Charles R 3,508 12.3100 3,508 12.3100 43,183 11 11.6400 -2,350 -5.44
2014-10-20 ANGO Greiner Charles R 3,298 15.6300 3,298 15.6300 51,548
2013-11-14 ANGO Greiner Charles R 4,373 15.4610 4,373 15.4610 67,611
2013-11-13 ANGO Greiner Charles R 2,392 15.4020 2,392 15.4020 36,842
2013-05-09 ANGO Greiner Charles R 1,495 10.3800 1,495 10.3800 15,518

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ANGO / AngioDynamics, Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Charles R Greiner as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2016-05-09 2016-05-06 4 ANGO ANGIODYNAMICS INC
Common Stock
S - Sale -3,508 20,910 -14.37 12.31 -43,183 257,402
2015-08-07 2015-08-06 4 ANGO ANGIODYNAMICS INC
Common Stock
F - Taxes -465 24,418 -1.87 15.91 -7,398 388,490
2015-08-05 2015-08-05 4 ANGO ANGIODYNAMICS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -14,100 0 -100.00
2015-08-05 2015-08-05 4 ANGO ANGIODYNAMICS INC
Common Stock
F - Taxes -13,793 24,883 -35.66 15.81 -218,067 393,400
2015-08-05 2015-08-05 4 ANGO ANGIODYNAMICS INC
Common Stock
M - Exercise 14,100 38,676 57.37 15.27 215,307 590,583
2015-08-05 2015-08-03 4 ANGO ANGIODYNAMICS INC
Common Stock
F - Taxes -561 24,576 -2.23 15.54 -8,718 381,911
2015-08-05 2015-08-03 4 ANGO ANGIODYNAMICS INC
Common Stock
F - Taxes -633 23,137 -2.66 15.54 -9,837 359,549
2015-07-29 2015-07-27 4 ANGO ANGIODYNAMICS INC
Common Stock
F - Taxes -411 25,770 -1.57 15.63 -6,424 402,785
2015-07-24 2015-07-22 4 ANGO ANGIODYNAMICS INC
Performance Right
A - Award 5,501 5,501
2015-07-24 2015-07-22 4 ANGO ANGIODYNAMICS INC
Non-Qualified Stock Option (right to buy)
A - Award 14,153 14,153
2015-07-24 2015-07-22 4 ANGO ANGIODYNAMICS INC
Common Stock
A - Award 4,126 26,181 18.71
2014-10-21 2014-10-20 4 ANGO ANGIODYNAMICS INC
Common Stock
S - Sale -3,298 22,055 -13.01 15.63 -51,548 344,720
2014-08-08 2014-08-06 4 ANGO ANGIODYNAMICS INC
Common Stock
F - Taxes -465 25,353 -1.80 14.75 -6,859 373,957
2014-08-08 2014-08-03 4 ANGO ANGIODYNAMICS INC
Common Stock
F - Taxes -633 25,818 -2.39 14.69 -9,299 379,266
2014-08-08 2014-08-03 4 ANGO ANGIODYNAMICS INC
Common Stock
F - Taxes -572 26,451 -2.12 14.69 -8,403 388,565
2014-08-08 2014-08-03 4 ANGO ANGIODYNAMICS INC
Common Stock
F - Taxes -646 27,023 -2.33 14.69 -9,490 396,968
2014-07-29 2014-07-25 4 ANGO ANGIODYNAMICS INC
Performance Right
A - Award 6,055 6,055
2014-07-29 2014-07-25 4 ANGO ANGIODYNAMICS INC
Non-Qualified Stock Option (right to buy)
A - Award 13,066 13,066
2014-07-29 2014-07-25 4 ANGO ANGIODYNAMICS INC
Common Stock
A - Award 4,541 27,669 19.63
2013-11-15 2013-11-14 4 ANGO ANGIODYNAMICS INC
Non-Qualified Stock Option (right to buy)
M - Exercise -4,373 0 -100.00
2013-11-15 2013-11-14 4 ANGO ANGIODYNAMICS INC
Common Stock
S - Sale -4,373 23,128 -15.90 15.46 -67,611 357,582
2013-11-15 2013-11-14 4 ANGO ANGIODYNAMICS INC
Common Stock
M - Exercise 4,373 27,501 18.91 13.18 57,636 362,463
2013-11-15 2013-11-13 4 ANGO ANGIODYNAMICS INC
Common Stock
S - Sale -2,392 23,128 -9.37 15.40 -36,842 356,217
2013-11-05 2013-11-01 4 ANGO ANGIODYNAMICS INC
Performance Right
A - Award 6,852 6,852
2013-09-06 2013-09-04 4 ANGO ANGIODYNAMICS INC
Common Stock
F - Taxes -795 25,520 -3.02 10.96 -8,713 279,699
2013-08-08 2013-08-06 4 ANGO ANGIODYNAMICS INC
Non-Qualified Stock Option (right to buy)
A - Award 16,740 16,740
2013-08-08 2013-08-06 4 ANGO ANGIODYNAMICS INC
Common Stock
A - Award 5,139 26,315 24.27
2013-08-06 2013-08-03 4 ANGO ANGIODYNAMICS INC
Common Stock
F - Taxes -742 21,176 -3.39 12.04 -8,934 254,959
2013-08-06 2013-08-03 4 ANGO ANGIODYNAMICS INC
Common Stock
F - Taxes -646 21,918 -2.86 12.04 -7,778 263,893
2013-08-06 2013-08-03 4 ANGO ANGIODYNAMICS INC
Common Stock
F - Taxes -657 22,564 -2.83 12.04 -7,910 271,671
2013-05-16 2013-05-09 4 ANGO ANGIODYNAMICS INC
Common Stock
S - Sale -1,495 23,221 -6.05 10.38 -15,518 241,034
2012-12-10 3 ANGO ANGIODYNAMICS INC
Common Stock
7,512
2012-12-10 3 ANGO ANGIODYNAMICS INC
Common Stock
1,875
2012-12-10 3 ANGO ANGIODYNAMICS INC
Common Stock
3,050
2012-12-10 3 ANGO ANGIODYNAMICS INC
Common Stock
4,650
2012-12-10 3 ANGO ANGIODYNAMICS INC
Common Stock
7,000
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)